IL6 and COVID-19: In another, of individuals examined 4 months after COVID-19 symptom onset, no difference was found in levels of IL-6, IL-10, IP-10, sCD14, or sCD163 — the latter two are markers of monocyte activation — in those with and without PASC (71).